Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small integral membrane protein 9 (SMIM9) is a poorly characterized, predicted single-pass membrane protein encoded by the SMIM9 gene (also known as CXorf68), located on the X chromosome in humans[7][5]. It is classified as an integral membrane protein with uncertain molecular function, though some databases propose it may act as a scaffold/adaptor protein[2]. Its expression is not detected in major tissue surveys[3]. No evidence currently supports its role as a therapeutic target, drug target, or biomarker, nor is it classified in major molecular families such as G protein-coupled receptors, ion channels, enzymes, or transporters[5][16][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small integral membrane protein 9 (SMIM9).